West Pharmaceutical Services, Inc. has established itself as a key player in the healthcare sector with a solid product portfolio in containment and delivery systems for injectable drugs. The stock represents a viable investment opportunity given its current market position and potential for growth. Investors should regard its strong presence in multiple global regions as a valuable asset to its market influence.
The company demonstrates a balanced set of fundamental scores with strengths in several key areas.
Rating Category | Score | Visual |
---|---|---|
Discounted Cash Flow | 4 | |
Return on Equity | 5 | |
Return on Assets | 5 | |
Debt to Equity | 3 | |
Price to Earnings | 1 | |
Price to Book | 1 |
The historical scores provide a backdrop for understanding the company's performance over time.
Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
---|---|---|---|---|---|---|---|
2025-06-05 | 3 | 4 | 5 | 5 | 3 | 1 | 1 |
Historical | 0 | 4 | 5 | 5 | 3 | 1 | 1 |
Current analyst projections present a wide range indicating potential stock return variance.
High | Low | Median | Consensus |
---|---|---|---|
393 | 250 | 250 | 297.67 |
The sentiment leans towards a buy consensus, underpinning favorable future expectations.
Recommendation | Count | Visual |
---|---|---|
Strong Buy | 0 | |
Buy | 9 | |
Hold | 2 | |
Sell | 0 | |
Strong Sell | 0 |
West Pharmaceutical Services, Inc. is positioned well with strong fundamentals in several key areas, notably return on equity and assets. Analyst sentiments are positive, further reinforced by favorable price targets. However, potential investors should be aware of the variance in analyst evaluations and market fluctuations. While the company holds significant market power globally, risks such as competitive pressures and market volatility should be considered.